These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2081450)

  • 1. [LH-RH analogs in mammary carcinoma: experimental aspects].
    Scambia G; Benedetti Panici P; De Vincenzo R; Isola G; Mancuso S
    Drugs Exp Clin Res; 1990; 16 Suppl():39-46. PubMed ID: 2081450
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
    Schally AV; Redding TW; Comaru-Schally AM
    Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
    Redding TW; Schally AV
    Prog Clin Biol Res; 1988; 262():217-40. PubMed ID: 2897695
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gonadotropin-releasing hormone analogues in the treatment of metastatic breast carcinoma].
    Nesković-Konstantinović Z; Radulović S; Vuletić L
    Srp Arh Celok Lek; 1993; 121(1-2):33-5. PubMed ID: 8202820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of a new analogue of luteinizing hormone releasing hormone, ICI 118630, on the growth of rat mammary tumours [proceedings].
    Nicholson RI; Finney EJ; Maynard PV
    J Endocrinol; 1978 Nov; 79(2):51P-52P. PubMed ID: 366064
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
    Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in prolactin receptor affinity in the rat mammary tumor model after treatment with analogs of somatostatin and LH-RH.
    Kadar T; Redding TW; Ben-David M; Schally AV
    Mater Med Pol; 1988; 20(4):219-23. PubMed ID: 2907923
    [No Abstract]   [Full Text] [Related]  

  • 10. [History of clinical studies on hypothalamic hormone analogs in Mexico].
    Schally AV; González Bárcena D
    Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour potential of a new luteinizing hormone releasing hormone analogue, ICI 118630.
    Nicholson RI; Walker KJ; Maynard PV
    Eur J Cancer (1965); 1980; Suppl 1():295-9. PubMed ID: 6459236
    [No Abstract]   [Full Text] [Related]  

  • 12. [New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin].
    Schally AV
    An R Acad Nac Med (Madr); 2004; 121(3):493-500. PubMed ID: 15751842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and experimental basis of therapy with LHRH agonists in women.
    Sandow J; Fraser HM; Geisthövel F
    Prog Clin Biol Res; 1986; 225():1-27. PubMed ID: 3024177
    [No Abstract]   [Full Text] [Related]  

  • 14. [LHRH analogs--a new treatment in hormone-dependent tumors].
    Wilking N; Rutqvist LE; Theve T
    Lakartidningen; 1988 Feb; 85(8):620-3. PubMed ID: 3280927
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy targeted to cancers through tumoral hormone receptors.
    Schally AV; Nagy A
    Trends Endocrinol Metab; 2004 Sep; 15(7):300-10. PubMed ID: 15350601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers.
    Schally AV; Comaru-Schally AM; Redding TW
    Proc Soc Exp Biol Med; 1984 Mar; 175(3):259-81. PubMed ID: 6141569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
    Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
    Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of LHRH analogs in gynecologic oncology].
    Sismondi P; Giai M; Defabiani E; Cortese P
    Minerva Ginecol; 1990 May; 42(5):177-86. PubMed ID: 2197573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LH-RH analogues in metastatic breast cancer: first results].
    Terzoli E; Izzo F; Nisticò C; Lucatelli S; Ranuzzi M
    G Ital Oncol; 1988; 8(2):59-63. PubMed ID: 3065224
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct antitumor effects of LH-RH analogs.
    Foekens JA; Klijn JG
    Recent Results Cancer Res; 1992; 124():7-17. PubMed ID: 1615221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.